3Coleman N, Birley HD, Renton AM. Immunological events in regressing genital warts. Am J Clin Pathol, 1994, 102(6):768-774.
4Leigh IM, Glover MJ. Cutaneous warts and tumours in immunosuppressed patients. J R Soc Med, 1995, 88(2):61-62.
5Durst M, Bosch FX, Glitz D, et al. Inverse relationship between human papillomavirus(HPV)16 type early gene expression and cell differentiation in nude mouse epithelial cysts and tumors induced by HPV-positive human cell lines. J Virol, 1991,65(2):796-804.
6Rueseh MN, Stubenrauch F, Laimins LA. Activation of papillomavirus late gene transcription and genome amplification upon differentation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J Virol,1998,72(6): 5016-5024.
6Koutsky L.Epidemiology of genital human papillomavirus infection[J].Am J Med,1997,102(5A):3.
7刘映麟.高危妊娠监护治疗学[M].北京:北京医科大学中国协和大学联合出版社,1997.174.
8Laboratory Centre for Disease Control.Canadian STD Guidelines[M].Ottawa:Health Canada,2000.191-200.
9Clinical Effectiveness Group.National guideline for the management of the management of anogenital warts[J].Sex Transm Infect,2001,75(Suppll):71-75.
10Swinehart JM, Speding M, Phillips S, et al. Intralesioanl fluorouracil epinephrine injectable gel for treatment of condylomata acuminate:a phase 3 clinical study. Arch Dermatol, 1997,133:67-73.
